MedTrace Logo

Efficacy and Safety of Mildronate for Acute Ischemic Stroke

NCT01800357 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2013-02-27

No results posted yet for this study

Summary

This study seeks to evaluate the efficacy and safety of mildronate injection in treating acute ischemic stroke

Conditions

  • Acute Ischemic Stroke

Interventions

DRUG

infusion of mildronate

infusion of mildronate(500mg) once a day and for 14 days

DRUG

placebo

infusion of plabcebo once a day and for 14 days

DRUG

aspirin

infusion of aspirin (100mg) once a day for days

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Gang Zhao, MD · the Department of Neurology , Xijing Hospital

  • Yi Zhu, MD · the Department of Neurology , Xijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-06-30
Completion
2014-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01800357 on ClinicalTrials.gov